FALCINI, FERNANDA
 Distribuzione geografica
Continente #
NA - Nord America 4097
EU - Europa 2262
AS - Asia 169
SA - Sud America 8
AF - Africa 7
Continente sconosciuto - Info sul continente non disponibili 3
OC - Oceania 2
Totale 6548
Nazione #
US - Stati Uniti d'America 4085
IE - Irlanda 542
PL - Polonia 443
SE - Svezia 404
IT - Italia 319
UA - Ucraina 135
FI - Finlandia 126
DE - Germania 117
CN - Cina 72
TR - Turchia 72
GB - Regno Unito 61
FR - Francia 60
BE - Belgio 21
RU - Federazione Russa 12
AT - Austria 11
CA - Canada 11
VN - Vietnam 8
SC - Seychelles 7
ES - Italia 5
IR - Iran 5
PE - Perù 4
CL - Cile 3
EU - Europa 3
IN - India 3
JP - Giappone 3
NL - Olanda 3
AU - Australia 2
TH - Thailandia 2
BR - Brasile 1
CH - Svizzera 1
HK - Hong Kong 1
HU - Ungheria 1
ID - Indonesia 1
IL - Israele 1
MX - Messico 1
PT - Portogallo 1
SA - Arabia Saudita 1
Totale 6548
Città #
Fairfield 659
Chandler 637
Dublin 542
Warsaw 436
Woodbridge 303
Cambridge 272
Jacksonville 243
Ashburn 239
Seattle 230
Wilmington 229
Houston 201
Altamura 171
Princeton 166
Lawrence 158
Ann Arbor 109
Boston 104
Buffalo 78
Medford 72
Izmir 70
Beijing 59
Boardman 58
San Diego 31
Florence 25
Norwalk 24
Brussels 21
Falls Church 17
Salerno 17
Andover 16
Milan 15
Vienna 11
Toronto 10
Frankfurt Am Main 7
Guangzhou 7
Dong Ket 6
Phoenix 5
Verona 5
Auburn Hills 4
Barcelona 4
Munich 4
Trumbull 4
Arezzo 3
Detroit 3
Laurel 3
Lima 3
Los Angeles 3
Polska 3
Radomsko 3
Saint Petersburg 3
Santiago 3
Ankara 2
Chicago 2
Düsseldorf 2
Groningen 2
Hamburg 2
Hefei 2
Jesi 2
Kish 2
Novara 2
Okimachi 2
Old Bridge 2
Philadelphia 2
Redmond 2
Redwood City 2
Sydney 2
Washington 2
Arnsberg 1
Bangkok 1
Baotou 1
Bremen 1
Bucine 1
Cascina 1
Caserta 1
Cecina 1
Central District 1
Cergy 1
Chengdu 1
Dearborn 1
Dessau 1
El Segundo 1
Follonica 1
Hanover 1
Helsinki 1
Jakarta 1
Jinan 1
Jinhua 1
Kashan 1
Leeds 1
London 1
Lucca 1
Mahé 1
Mexico City 1
Monmouth Junction 1
Montréal 1
Novafeltria 1
Palermo 1
Paris 1
Parma 1
Piera 1
Piombino 1
Pisa 1
Totale 5363
Nome #
Bone mass and quality in patients with juvenile idiopathic arthritis: longitudinal evaluation of bone mass determinants using dual energy X-ray absorptiometry, peripheral quantitative computed tomography, and quantitative ultrasonography. 220
Kawasaki disease in a girl with turner syndrome: A remarkable association 202
Comparison of bone mass and quality determinants in adolescents and young adults with juvenile systemic lupus erythematosus (JSLE) and juvenile idiopathic arthritis (JIA) 189
Serum osteopontin as a predictive marker of responsiveness to methotrexate in juvenile idiopathic arthritis. 115
Cross-sectional and longitudinal evaluation of bone mass and quality in children and young adults with juvenile onset systemic lupus erythematosus (JSLE): role of bone mass determinants analyzed by DXA, PQCT and QUS. 115
Fibroblast growth factor 23 (FGF23) gene polymorphism in children with Kawasaki syndrome (KS) and susceptibility to cardiac abnormalities. 114
Safety and efficacy of infliximab and adalimumab for refractory uveitis in juvenile idiopathic arthritis: 1-year followup data from the Italian Registry. 114
Comparison of bone mass and quality determinants in adolescents and young adults with juvenile systemic lupus erythematosus (JSLE) and juvenile idiopathic arthritis (JIA). 94
Determinants of Vitamin D Levels in Children, Adolescents, and Young Adults with Juvenile Idiopathic Arthritis. 91
Vitamin D levels in children, adolescents, and young adults with juvenile-onset systemic lupus erythematosus: a cross-sectional study. 89
Lack of association between the HLA-DRB1 locus and post-streptococcal reactive arthritis and acute rheumatic fever in italian children 82
Coeliac disease in patients with Kawasaki disease. Is there a link? 82
Loss of efficacy during long-term infliximab therapy for sight-threatening childhood uveitis. 81
Human parvovirus B19 infection: its relationship with systemic lupus erythematosus. 80
AB0976 Association of Vitamin D Receptor Polymorphisms with Juvenile Idiopathic Arthritis (JIA) 80
Oxidative stress in Systemic Sclerosis. 75
Comparison of quantitative calcaneal ultrasound and dual energy X-ray absorptiometry in the evaluation of osteoporotic risk in children with chronic rheumatic diseases. 74
Comparable Efficacy of Abatacept Used as First-line or Second-line Biological Agent for Severe Juvenile Idiopathic Arthritis-related Uveitis 73
Osteoprotegerin serum levels in children with type 1 diabetes: a potential modulating role in bone status. 72
Vitamin D levels and effects of vitamin D replacement in children with periodic fever, aphthous stomatitis, pharyngitis, and cervical adenitis (PFAPA) syndrome 72
EFFECT ON LUNG FUNCTION OF METHOTREXATE AND NON-STEROID ANTI-INFLAMMATORY DRUGS IN CHILDREN WITH JUVENILE RHEUMATOID ARTHRITIS 72
Thyroid function, autoimmune thyroiditis and coeliac disease in juvenile idiopathic arthritis 72
Severe cutaneous manifestations in a child with refractory Kawasaki disease. 71
Health related quality of life measure in systemic pediatric rheumatic diseases and its translation to different languages: An international collaboration 70
CATASTROPHIC ANTIPHOSPHOLIPID ANTIBODY SYNDROME IN PEDIATRIC SYSTEMIC LUPUS ERYTHEMATOSUS 69
REACTIVE ARTHRITIS TRIGGERED BY YERSINIA ENTEROCOLITICA: A REVIEW OF 18 PEDIATRIC CASES 69
Prevalence and clinical significance of anti-cyclic citrullinated peptide antibodies in juvenile idiopathic arthritis. 69
SAT0505 Severe Vitamin D Deficiency in Patients with Kawasaki Disease: its Possible Role in the Risk to Develop Coronary Artery Damage 69
Cross-sectional and longitudinal evaluation of bone mass in children and young adults with juvenile idiopathic arthritis: the role of bone mass determinants in a large cohort of patients. 67
Stiff skin syndrome: evidence for an inflammation-independent fibrosis? 66
Circulating leptin levels in juvenile idiopathic arthritis: a marker of nutritional status? 66
Clinical-Serological Characterization and Treatment Outcome of a Large Cohort of Italian Children with Pediatric Autoimmune Neuropsychiatric Disorder Associated with Streptococcal Infection and Pediatric Acute Neuropsychiatric Syndrome 62
Diene-conjugates and antibodies against oxidized low-density lipoproteins in systemic sclerosis. 62
Mycophenolate mofetil for the treatment of juvenile onset SLE: a multicenter study. 61
Bone mass predictors in a large cohort of children with juvenile idiopathic arthritis (JIA) 61
Severe vitamin D deficiency in patients with Kawasaki disease: a potential role in the risk to develop heart vascular abnormalities? 59
Henoch Schonlein Purpura in Childhood:Epidemiological and Clinical Analysis of 150 CasesOver a 5-year Period and Review of Literature 59
Bone status over one-year etanercept treatment in juvenile idiopathic arthritis 57
Diagnosing Kawasaki syndrome: the need for a new clinical tool. 57
Sustained improvement of a girl affected with Devic’sdisease over 2 years of mycophenolate mofetil treatment 57
INCIDENCE OF OCCULT CANCER IN CHILDREN PRESENTING WITH MUSCULOSKELETAL SYMPTOMS: A 10-YEAR SURVEY IN A PEDIATRIC RHEUMATOLOGY UNIT 55
Clinical correlations of plasma angiotensin converting enzyme (ACE) activity in systemic sclerosis: a longitudinal study of plasma ACE level, endothelial injury and lung involvement. 53
Methotrexate-associated appearance and rapid progression of rheumatoid nodules in systemic-onset juvenile rheumatoid arthritis. 53
Reduction of bcl-2 in T cells during immunosuppressive therapy in patients with severe juvenile onset systemic lupus erythematosus. 51
Increased circulating nerve growth factor is directly correlated with disease activity in juvenile chronic arthritis. 50
OSTEOPOROSIS IN JUVENILE SYSTEMIC LUPUS ERYTHEMATOSUS: A LONGITUDINAL STUDY ON THE EFFECT OF STEROIDS ON BONE MINERAL DENSITY 50
Are Angiotensin Converting Enzyme and von Willebrand factor circulating levels useful surrogate parameters to monitor disease activity in Kawasaki disease? 50
Mutations in GALNT3 GENE: Two adolescents with tumoral calcinosis-hyperphosphatemia 50
PReS-FINAL-2053: Vitamin D receptor polymorphisms in a cohort of Italian patients with juvenile idiopathic arthritis 49
Bcl-2, p53 and c-myc expression in juvenile dermatomyositis. 48
Longitudinal evaluation of bone mass in adolescents and young adults with juvenile idiopathic arthritis: the role of bone mass determinants in a large cohort of patients 48
Reflex sympathetic dystrophy in children. 47
NEPRILYSIN LEVELS IN PLASMA AND SYNOVIAL FLUID OF JUVENILE IDIOPATHIC ARTHRITIS PATIENTS. RHEUMATOL INT. 2005 JUN;25(5):336-40. EPUB 2004 MAR 3. 45
COMPARISON OF QUANTITATIVE CALCANEAL ULTRASOUND AND DUAL X-RAY ABSORPTIOMETRY IN THE EVALUATION OF OSTEOPOROTIC RISK IN CHILDREN WITH CHRONIC RHEUMATIC DISEASES 45
Acute febrile cholestasis as inaugural manifestation of Kawasaki’s disease. 44
Bilateral renal artery stenosis in Kawasaki disease: a report of two cases. 42
THE PRIMARY ROLE OF STEROIDS ON THE OSTEOPOROSIS IN JUVENILE RHEUMATOID ARTHRITIS EVALUATED BY DUAL ENERGY X-RAY ABSORPTIOMETRY 42
Cross-Sectional Evaluation of Plasma Vitamin D Levels in a Large Cohort of Italian Patients with Pediatric Autoimmune Neuropsychiatric Disorders Associated with Streptococcal Infections 42
Le malattie reumatiche in età Pediatrica 41
Association of low bone mass with vitamin d receptor gene and calcitonin receptor gene polymorphisms in juvenile idiopathic arthritis. 41
Bone status evaluation with calcaneal ultrasound in children with chronic rheumatic diseases. A one year followup study. 41
IMMUNOLOGICAL FINDINGS IN KAWASAKI DISEASE: AN EVALUATION IN A COHORT OF ITALIAN CHILDREN 40
EFFICACY AND SAFETY OF IMMUNOGLOBULIN RETREATMENT IN KAWASAKI DISEASE 39
Osteoprotegerin serum levels in Kawasaki disease: an additional potential marker in predicting children with coronary artery involvement 39
PULMONARY FUNCTION IN CHILDREN AFFECTED BY JUVENILE SPONDYLOARTHROPATHY 38
Lupus-like onset of recurrent Kawasaki disease in an adolescent boy 38
ANGIOTENSIN CONVERTING ENZYME A NEW TOOL FOR THE FOLLOW-UPOF ENDOTHELIAL INJURY IN PEDIATRIC VASCULITIDES 38
Evidence of immune activation against oxidized lipoproteins in inactive phases of juvenile chronic arthritis. 37
A boy with bizarre hands mimicking an inflammatory chronic disease. 37
Anti-TNF agents for the treatment of JIA-related Refractory Uveitis: 2010 UPDATE from the Italian Registry 37
Acute lymphocytic leukemia with dermatomyositis-like onset in childhood 36
SYSTEMIC VASCULITIS IN JUVENILE DERMATOMYOSITIS: A FATAL CASE 35
Sustained improvement of a girl affected with Devics’s disease over 2 years of mycophenolate mofetil treatment. 35
Cross-selectional and longitudinal evaluation of bone mass in children and young adults with juvenile idiopatic arthritis: the role of bone mass determination in a large cohort of patients. 35
DEFLAZACORT IN PEDIATRIC RHEUMATIC DISEASES NEEDS A FREQUENT FOLLOW-UP OF BONE DENSITOMETRY 35
Juvenile psoriatic arthritis and acquired sensorineural hearing loss in a teenager: Is there an association? 35
Juvenile dermatomyositis and celiac disease 34
Clinical overview and outcome in a cohort of children with polyarteritis nodosa. 34
Update on Kawasaki disease: The 25 year experience at the "A. Mayer" Children's Hospital, Florence 34
Usefulness of bone ultrasound techniques in pediatric rheumatic diseases. 34
CORRELATION BETWEEN CLINICAL AND ULTRASOUND EVALUATION ASSESSMENT OF THE KNEE IN CHILDREN WITH MONO-ARTICULAR OR PAUCIARTICULAR JUVENILE RHEUMATOID ARTHRITIS 34
Lung involvement in Juvenile dermatomyositis (JDM): Muscle strenght and pulmonary function tests in children with JDM 34
Osteopontin in juvenile idiopathic arthritis: A potential role in early prediction of disease severity and MTX responsiveness? 34
Clinical and laboratory features and disease outcome of kawasaki disease: the analysis of our experience and literature review. 33
[Articular manifestations of 11 cases of Kawasaki syndrome observed in Toscana]. 32
HYDROPS OF GALLBLADDER REQUIRING CHOLECYSTECTOMY IN KAWASAKI SYNDROME 32
AB0481 Vitamin D Levels in Children, Adolescents, and Young Adults with Juvenile Onset Systemic Lupus Erythematosus: A Transversal Study 32
Bone mass and quality in Juvenile systemic lupus erythematosus (JSLE) 32
INTRAVENOUS ADMINISTRATION OF ALENDRONATE COUNTERACTS THE IN VIVO EFFECTS OF GLUCOCORTICOIDS ON BONE REMODELLING 31
Recurrent monoarthritis in an 11-year-old boy with occult coeliac disease. Successful and stable remission after gluten-free diet. 31
Asymmetrical masseter muscle thickness in oligoarticular jia patients with monolateral TMJ involvement: Sonographic evaluation. 31
Clinical utility of noninvasive methods in the evaluation of scleroderma lung in pediatric age 30
HLA DRB1 alleles in post-streptococcal reactive arthritis and rheumatic fever do not differ in Italian patients. 29
Recurrent limp in a young boy. 29
Severe abdominal involvement as initial manifestation of cutaneous polyarteritis nodosa in a young girl. 29
Bone mass and quality in juvenile idiopahic arthritis: comparison of the roleof bone mass determinants using DXA, PQCT, and QUS 29
Cancer incidence in Italian contaminated sites 29
Studio prospettico della funzione respiratoria in bambini affetti da Lupus Eritematoso Sistemico 29
THU0374 Vitamin D Levels and Effects of Vitamin D Replacement in Children with Periodic Fever, Aphthous Stomatitis, Pharyngitis, and Cervical Adenitis (PFAPA) Syndrome 29
Microparticles are significantly increased in the blood of children with Kawasaki disease (KD). 28
Totale 5703
Categoria #
all - tutte 11323
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 11323


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2017/2018174 0000 00 017 31506313
2018/2019798 17131712 6813 287 13113292205
2019/20201341 1539429111 140158 135167 1307712126
2020/2021888 825559101 43107 1677 701325591
2021/2022943 231144258 3132 4855 3224170314
2022/20232098 258510100228 184469 3490 0000
Totale 6660